PortfoliosLab logoPortfoliosLab logo
ALT vs. BLNK
Performance
Return for Risk
Drawdowns
Volatility
Dividends
Financials

Performance

ALT vs. BLNK - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Altimmune, Inc. (ALT) and Blink Charging Co. (BLNK). The values are adjusted to include any dividend payments, if applicable.

Loading charts...

Returns By Period

In the year-to-date period, ALT achieves a -21.33% return, which is significantly higher than BLNK's -22.49% return.


ALT

1D
-4.70%
1M
-10.13%
6M
-49.29%
YTD
-21.33%
1Y
-21.33%
3Y*
-3.60%
5Y*
-20.72%
10Y*
-29.17%
ALL TIME*
-19.35%

BLNK

1D
5.51%
1M
-17.69%
6M
-27.18%
YTD
-22.49%
1Y
-45.63%
3Y*
-56.64%
5Y*
-56.84%
10Y*
ALL TIME*
-28.54%
*Multi-year figures are annualized to reflect compound growth (CAGR)

Liquidity Comparison


PositionAvg. Volume Value (2W)Avg. Volume Value (1M)Avg. Volume Value (3M)
$14.41M$12.19M$11.44M
$761.98K$662.38K$1.54M

ALT vs. BLNK - Yearly Performance Comparison


2026 (YTD)20252024202320222021202020192018
ALT
Altimmune, Inc.
-21.33%-49.93%-35.91%-31.61%79.59%-18.79%496.83%-8.25%-95.42%
BLNK
Blink Charging Co.
-22.49%-52.01%-59.00%-69.10%-58.62%-37.99%2,198.39%8.14%-80.61%

Correlation

The correlation between ALT and BLNK is 0.33, which is low. Their historical price movements had little consistent relationship.


Correlation
Correlation (1Y)
Focuses on recent behavior, but can change the most.

0.33

Correlation (3Y)
Balances recent behavior with more history.

0.34

Correlation (5Y)
Shows whether the relationship held over a longer period.

0.35

Correlation (All Time)
Calculated using the full available price history since Feb 13, 2018

0.27

Fundamentals

Market Cap

ALT:

$250.65M

BLNK:

$61.70M

EPS

ALT:

-$0.87

BLNK:

-$0.60

PS Ratio

ALT:

8.27K

BLNK:

0.61

PB Ratio

ALT:

1.24

BLNK:

1.37

Total Revenue (TTM)

ALT:

$36.00K

BLNK:

$103.40M

Gross Profit (TTM)

ALT:

-$14.92M

BLNK:

$24.62M

EBITDA (TTM)

ALT:

-$93.48M

BLNK:

-$58.57M

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Return for Risk

ALT vs. BLNK — Risk / Return Rank

Compare historical risk-adjusted metric ranks over the past 12 months.

ALT
ALT Risk / Return Rank: 3131
Overall Rank
ALT Sharpe Ratio Rank: 3030
Sharpe Ratio Rank
ALT Sortino Ratio Rank: 3232
Sortino Ratio Rank
ALT Omega Ratio Rank: 3232
Omega Ratio Rank
ALT Calmar Ratio Rank: 3131
Calmar Ratio Rank
ALT Martin Ratio Rank: 3131
Martin Ratio Rank

BLNK
BLNK Risk / Return Rank: 2525
Overall Rank
BLNK Sharpe Ratio Rank: 2222
Sharpe Ratio Rank
BLNK Sortino Ratio Rank: 2525
Sortino Ratio Rank
BLNK Omega Ratio Rank: 2626
Omega Ratio Rank
BLNK Calmar Ratio Rank: 2323
Calmar Ratio Rank
BLNK Martin Ratio Rank: 2929
Martin Ratio Rank
The rank (0–100) uses a weighted average of the Sharpe, Sortino, Omega, Calmar, and Martin percentile ranks for the trailing 12 months. Higher means stronger historical risk-adjusted performance within the peer group.

ALT vs. BLNK - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Altimmune, Inc. (ALT) and Blink Charging Co. (BLNK). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.


ALTBLNKDifference
Sharpe ratioReturn per unit of total volatility

+0.17

Sortino ratioReturn per unit of downside risk

+0.32

Omega ratioGain probability vs. loss probability

0.99

0.96

+0.03

Calmar ratioReturn relative to maximum drawdown

-0.40

-0.58

+0.18

Martin ratioReturn relative to average drawdown

-0.67

-0.79

+0.12

ALT vs. BLNK - Sharpe Ratio Comparison

The current ALT Sharpe Ratio is -0.34, which is higher than the BLNK Sharpe Ratio of -0.50. The chart below compares the historical Sharpe Ratios of ALT and BLNK, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.


Loading charts...

Drawdowns

ALT vs. BLNK - Drawdown Comparison

The maximum ALT drawdown since its inception was -99.63%, roughly equal to the maximum BLNK drawdown of -99.23%. Use the drawdown chart below to compare losses from any high point for ALT and BLNK.


Loading charts...

Drawdown Indicators


ALTBLNKDifference

Max Drawdown

Largest peak-to-trough decline

-99.63%

-99.23%

-0.40%

Max Drawdown (1Y)

Largest decline over 1 year

-58.09%

-81.20%

+23.11%

Max Drawdown (3Y)

Largest decline over 3 years

-81.25%

-93.15%

+11.90%

Max Drawdown (5Y)

Largest decline over 5 years

-90.45%

-99.00%

+8.55%

Max Drawdown (10Y)

Largest decline over 10 years

-99.63%

Current Drawdown

Current decline from peak

-99.31%

-99.15%

-0.16%

Average Drawdown

Average peak-to-trough decline

-79.02%

-73.87%

-5.15%

Ulcer Index

Depth and duration of drawdowns from previous peaks

34.45%

59.76%

-25.31%

Volatility

ALT vs. BLNK - Volatility Comparison

The current volatility for Altimmune, Inc. (ALT) is 12.15%, while Blink Charging Co. (BLNK) has a volatility of 19.92%. This indicates that ALT experiences smaller price fluctuations and is considered to be less risky than BLNK based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


Loading charts...

Volatility by Period


ALTBLNKDifference

Volatility (1M)

Calculated over the trailing 1-month period

12.15%

19.92%

-7.77%

Volatility (6M)

Calculated over the trailing 6-month period

45.11%

57.82%

-12.71%

Volatility (1Y)

Calculated over the trailing 1-year period

68.95%

93.91%

-24.96%

Volatility (5Y)

Calculated over the trailing 5-year period, annualized

92.48%

83.14%

+9.34%

Volatility (10Y)

Calculated over the trailing 10-year period, annualized

149.74%

120.61%

+29.13%

Dividends

ALT vs. BLNK - Dividend Comparison

Neither ALT nor BLNK has paid dividends to shareholders.


PositionTTM202520242023202220212020201920182017
ALT
Altimmune, Inc.
0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%1,462.31%
BLNK
Blink Charging Co.
0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%

Financials

ALT vs. BLNK - Financials Comparison

This section allows you to compare key financial metrics between Altimmune, Inc. and Blink Charging Co.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


Values in USD except per share items

Frequently Asked Questions


ALT and BLNK have a correlation of 0.33, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

BLNK has higher volatility (19.92%) compared to ALT (12.15%). In terms of maximum drawdown, ALT dropped -99.63% vs BLNK's -99.23%.

ALT currently has the higher Sharpe Ratio (-0.34 vs -0.50), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.

Portfolio Optimizer

Find the right allocation for ALT and BLNK

Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.

Open Portfolio Optimizer